Cav1.4 dysfunction and congenital stationary night blindness type 2.

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology Animals Calcium Channel Agonists / pharmacology Calcium Channels, L-Type / genetics Eye Diseases, Hereditary / genetics Genetic Diseases, X-Linked / genetics Humans Mutation / physiology Myopia / genetics Night Blindness / genetics Retina / drug effects Synapses / drug effects
Calcium channel Cav1.4 Channel modulation Channelopathy Congenital stationary night blindness type 2 Retinal disease

Journal

Pflugers Archiv : European journal of physiology
ISSN: 1432-2013
Titre abrégé: Pflugers Arch
Pays: Germany
ID NLM: 0154720

Informations de publication

Date de publication:
09 2021
Historique:
received: 04 01 2021
accepted: 18 04 2021
revised: 14 04 2021
pubmed: 3 7 2021
medline: 24 2 2022
entrez: 2 7 2021
Statut: ppublish

Résumé

Cav1.4 L-type Ca

Identifiants

DOI: 10.1007/s00424-021-02570-x PMID: 34212239 PMC: PMC8370969
pubmed: 34212239
doi: 10.1007/s00424-021-02570-x
pii: 10.1007/s00424-021-02570-x
pmc: PMC8370969
doi:

Substances chimiques

CACNA1F protein, human 0
Calcium Channel Agonists 0
Calcium Channels, L-Type 0
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester 71145-03-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1437-1454

Informations de copyright

© 2021. The Author(s).

Références

Adv Exp Med Biol. 2002;514:439-50
pubmed: 12596937
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6861-6869
pubmed: 28002560
Eur J Hum Genet. 2002 Aug;10(8):449-56
pubmed: 12111638
Physiol Rev. 2018 Oct 1;98(4):2063-2096
pubmed: 30067155
J Biol Chem. 2012 Jan 6;287(2):832-47
pubmed: 22069316
J Neurosci. 1996 Jan;16(1):115-22
pubmed: 8613777
J Neurosci. 2005 Jan 5;25(1):252-9
pubmed: 15634789
Front Cell Neurosci. 2015 Aug 24;9:309
pubmed: 26379493
J Neurosci. 2003 Jul 9;23(14):6041-9
pubmed: 12853422
J Neurophysiol. 2004 Jul;92(1):477-83
pubmed: 14985410
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7553-8
pubmed: 15897456
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4846-56
pubmed: 26218913
Nature. 2010 Feb 18;463(7283):968-72
pubmed: 20139964
Arch Ophthalmol. 2003 Jul;121(7):1028-33
pubmed: 12860808
Pharmacol Rev. 2015 Oct;67(4):821-70
pubmed: 26362469
Ophthalmology. 2019 Sep;126(9):1273-1285
pubmed: 31443789
PLoS One. 2014 Jan 21;9(1):e86769
pubmed: 24466230
J Physiol. 2009 May 15;587(Pt 10):2353-64
pubmed: 19332495
J Biol Chem. 2001 Jun 22;276(25):22100-6
pubmed: 11285265
Ophthalmic Genet. 2018 Dec;39(6):741-748
pubmed: 30260717
Nat Rev Neurosci. 2012 Jul 18;13(8):542-55
pubmed: 22805911
J Biol Chem. 2012 Oct 19;287(43):36312-21
pubmed: 22936811
Nat Rev Genet. 2010 Sep;11(9):636-46
pubmed: 20717154
Prog Retin Eye Res. 2015 Mar;45:58-110
pubmed: 25307992
Nat Neurosci. 2006 Sep;9(9):1108-16
pubmed: 16921373
Sci Transl Med. 2019 May 15;11(492):
pubmed: 31092694
Hum Mutat. 2003 Feb;21(2):169
pubmed: 12552565
Mol Vis. 2005 Mar 02;11:179-83
pubmed: 15761389
Sci Rep. 2021 Feb 1;11(1):2732
pubmed: 33526839
Vis Neurosci. 2006 Jan-Feb;23(1):11-24
pubmed: 16597347
Br J Ophthalmol. 2016 Jan;100(1):115-21
pubmed: 25770143
Invest Ophthalmol Vis Sci. 2002 May;43(5):1595-603
pubmed: 11980879
Hum Mol Genet. 2016 Jun 15;25(12):2552-2563
pubmed: 27106101
Neurosci Lett. 2002 Sep 6;329(3):297-300
pubmed: 12183035
J Biol Chem. 2009 Oct 23;284(43):29809-16
pubmed: 19717559
Am J Hum Genet. 2006 Oct;79(4):657-67
pubmed: 16960802
Hum Mol Genet. 2005 Oct 15;14(20):3035-46
pubmed: 16155113
Neuroreport. 1998 Jul 13;9(10):2161-5
pubmed: 9694192
Channels (Austin). 2013 Nov-Dec;7(6):503-13
pubmed: 24051672
Mol Ther. 2016 Apr;24(4):678-84
pubmed: 26867951
PLoS One. 2013 May 13;8(5):e63853
pubmed: 23675510
Genet Med. 2015 Apr;17(4):271-8
pubmed: 25356976
Sci Rep. 2015 Jun 01;5:10731
pubmed: 26029863
Invest Ophthalmol Vis Sci. 2014 May 27;55(5):3285-94
pubmed: 24867912
Biosci Rep. 2020 Apr 30;40(4):
pubmed: 32207531
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15461-6
pubmed: 24003157
J Biol Chem. 2008 Jul 25;283(30):20733-44
pubmed: 18482979
Hum Mol Genet. 2014 Mar 15;23(6):1538-50
pubmed: 24163243
J Gen Physiol. 2018 Dec 3;150(12):1676-1687
pubmed: 30355583
J Biol Chem. 2020 Dec 11;295(50):17215-17226
pubmed: 33037074
J Neurosci. 2001 Aug 15;21(16):5944-51
pubmed: 11487617
J Physiol. 1984 Sep;354:557-75
pubmed: 6090654
J Biol Chem. 2016 Jul 22;291(30):15663-73
pubmed: 27226626
Adv Exp Med Biol. 2012;723:215-23
pubmed: 22183336
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9958-63
pubmed: 16777957
Hum Mol Genet. 2008 Jul 15;17(14):2084-100
pubmed: 18385099
J Mol Biol. 2020 Mar 27;432(7):2204-2216
pubmed: 32087201
Biomed Res Int. 2015;2015:907827
pubmed: 26075273
Channels (Austin). 2018 Jan 1;12(1):17-33
pubmed: 29179637
Nat Genet. 1998 Jul;19(3):264-7
pubmed: 9662400
J Physiol. 1992 Feb;447:235-56
pubmed: 1317429
Nippon Ganka Gakkai Zasshi. 2002 Dec;106(12):737-55; discussion 756
pubmed: 12610835
Nat Struct Mol Biol. 2009 Feb;16(2):107-13
pubmed: 19190664
J Neurosci. 1997 Oct 1;17(19):7297-306
pubmed: 9295376
Mol Ther. 2010 Jan;18(1):80-6
pubmed: 19904234
Elife. 2020 Sep 17;9:
pubmed: 32940604
J Neurosci. 2018 Jul 4;38(27):6145-6160
pubmed: 29875267
Acta Physiol (Oxf). 2012 Apr;204(4):479-86
pubmed: 21880116
J Neurophysiol. 2011 Dec;106(6):2922-35
pubmed: 21880934
Neuron. 2017 Mar 22;93(6):1359-1374.e6
pubmed: 28262416
Exp Eye Res. 2019 Feb;179:106-114
pubmed: 30445045
Eur J Neurosci. 2000 Oct;12(10):3537-48
pubmed: 11029623
Am J Ophthalmol. 2003 May;135(5):733-6
pubmed: 12719097
Ophthalmology. 2013 Oct;120(10):2072-81
pubmed: 23714322
J Neurosci. 2000 Feb 1;20(3):929-36
pubmed: 10648697
Mol Autism. 2020 Jan 8;11(1):4
pubmed: 31921405
Nature. 2016 Sep 8;537(7619):191-196
pubmed: 27580036
Physiol Rev. 2010 Oct;90(4):1461-506
pubmed: 20959621
J Neurochem. 2006 Mar;96(6):1648-58
pubmed: 16476079
Clin Exp Ophthalmol. 2005 Apr;33(2):129-36
pubmed: 15807819
J Neurosci. 2017 Jul 12;37(28):6761-6777
pubmed: 28592699
Orphanet J Rare Dis. 2012 Jan 25;7:8
pubmed: 22277662
Hum Genet. 2001 Feb;108(2):91-7
pubmed: 11281458
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):2039-48
pubmed: 15161873
Nat Genet. 1998 Jul;19(3):260-3
pubmed: 9662399
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15657-62
pubmed: 17028172
Ophthalmic Genet. 2018 Oct;39(5):659-661
pubmed: 30067413
J Biochem. 2006 Apr;139(4):705-14
pubmed: 16672271
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1610-6
pubmed: 11381068
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):505-15
pubmed: 18952919
J Neurosci. 2004 Feb 18;24(7):1707-18
pubmed: 14973233
Cell. 2004 Oct 1;119(1):19-31
pubmed: 15454078
Hum Mol Genet. 2017 Aug 1;26(15):2923-2932
pubmed: 28472301
J Biol Chem. 2014 Nov 7;289(45):31262-73
pubmed: 25258313
EMBO Mol Med. 2014 Feb;6(2):194-211
pubmed: 24150896
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5274-9
pubmed: 15793008
Neuroscience. 2008 Feb 19;151(4):1066-83
pubmed: 18206315
Mol Ther. 2010 Jan;18(1):87-92
pubmed: 19904236
J Neurosci Res. 2003 Jan 1;71(1):146-51
pubmed: 12478624
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):37
pubmed: 32437548
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5919-26
pubmed: 19578023
J Comp Neurol. 2008 Feb 10;506(5):745-58
pubmed: 18076080
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3150-3161
pubmed: 31335952
J Biol Chem. 2015 Jan 16;290(3):1505-21
pubmed: 25468907
Transl Vis Sci Technol. 2020 Oct 14;9(11):19
pubmed: 33117610
Gene Ther. 2003 Jun;10(11):977-82
pubmed: 12756418
J Gen Physiol. 1996 May;107(5):621-30
pubmed: 8740375
Strabismus. 2009 Oct-Dec;17(4):158-64
pubmed: 20001510
Diseases. 2018 May 21;6(2):
pubmed: 29883422
Biochim Biophys Acta. 2014 Aug;1838(8):2053-65
pubmed: 24796500
Channels (Austin). 2015;9(5):298-306
pubmed: 26274509
Europace. 2014 Dec;16(12):1828-37
pubmed: 24728418
Am J Hum Genet. 2006 Nov;79(5):973-7
pubmed: 17033974
Ophthalmic Genet. 2002 Jun;23(2):71-97
pubmed: 12187427
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):708-13
pubmed: 14744918
Mol Vis. 2007 Jun 15;13:887-919
pubmed: 17653034
Channels (Austin). 2013 Nov-Dec;7(6):514-23
pubmed: 24064553
Mol Pharmacol. 2013 Oct;84(4):643-53
pubmed: 23924992
Channels (Austin). 2017 Jan 2;11(1):34-45
pubmed: 27362349
Mol Vis. 2011;17:3262-70
pubmed: 22194652
J Physiol. 2006 Oct 1;576(Pt 1):87-102
pubmed: 16809371
Biochem J. 2014 Aug 15;462(1):15-24
pubmed: 25057889
J Biol Chem. 2011 Dec 9;286(49):42736-42748
pubmed: 21998310
Biochim Biophys Acta. 2013 Jul;1828(7):1598-607
pubmed: 23219801
J Med Genet. 2006 Aug;43(8):699-704
pubmed: 16505158
Nature. 2016 Dec 1;540(7631):144-149
pubmed: 27851729

Auteurs

Alexandra Koschak (A)

Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria. alexandra.koschak@uibk.ac.at.
ORCID: 0000-0001-5758-1166

Monica L Fernandez-Quintero (ML)

Institute of General, Inorganic and Theoretical Chemistry, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.
ORCID: 0000-0002-6811-6283

Thomas Heigl (T)

Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.
ORCID: 0000-0003-1571-8579

Marco Ruzza (M)

Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.

Hartwig Seitter (H)

Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.
ORCID: 0000-0003-2100-4193

Lucia Zanetti (L)

Institute of Pharmacy, Pharmacology and Toxicology, Center for Chemistry and Biomedicine, University of Innsbruck, Innrain 80-82/III, 6020, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyridines › Acides nicotiniques › 4-(2-(Trifluorométhyl)phényl)-2,6-diméthyl-5-nitro-1,4-dihydro-nicotinate de méthyle › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Eucaryotes › Animaux › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents cardiovasculaires › Vasoconstricteurs › Agonistes des canaux calciques › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de transport membranaire › Canaux ioniques › Canaux calciques › Canaux calciques de type L › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Maladies héréditaires de l'oeil › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Maladies génétiques liées au chromosome X › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Maladies de l'oeil › Troubles de la réfraction oculaire › Myopie › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Maladies de l'oeil › Héméralopie › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Organes des sens › Oeil › Rétine › Cav1.4 dysfunction and congenital stationary...
questionsmedicales.fr › Cellules › Structures cellulaires › Membrane cellulaire › Structures de la membrane cellulaire › Jonctions intercellulaires › Synapses › Cav1.4 dysfunction and congenital stationary...